Harry S. Wieand - Concepedia

Author

Harry S. Wieand

Also Known As

H S Wieand, H. S. WIEAND, H. S. Wieand, H. Sam Wieand, H. Wieand, H.S. Wieand, H.Sam Wieand, HARRY S. WIEAND, Harry S. Wieand, Harry Sam Wieand

Publications

10.6K

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic Mayo Clinic in Arizona Duluth Clinic WinnMed North Central Cancer Treatment Group

About

Harry S. Wieand is an author at Mayo Clinic specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	24	2.8K
2	Health Sciences	2	2	136
3	Natural Sciences	1	1	352
4	Public Health	1	1	53
5	Biochemistry	1	1	352

Harry S. Wieand

Publications

9.7K

Citations

H-Index

Page 1

	Year	Citations
Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma James E. Krook, C G Moertel, Leonard L. Gunderson, New England Journal of Medicine	1991	1.9K
Improving Adjuvant Therapy for Rectal Cancer by Combining Protracted-Infusion Fluorouracil with Radiation Therapy after Curative Surgery Michael J. O’Connell, James A. Martenson, Harry S. Wieand, New England Journal of Medicine	1994	1.1K
Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials Daniel J. Sargent, Harry S. Wieand, Daniel G. Haller, Journal of Clinical Oncology	2005	702
Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. John A. Laurie, C G Moertel, Thomas R. Fleming, Journal of Clinical Oncology Surgical Adjuvant TherapySurgical OncologyMayo ClinicCancer ManagementGastroenterology	1989	695
Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. M. J. OʼConnell, J A Mailliard, Michael Kahn, Journal of Clinical Oncology	1997	585
Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. M. J. OʼConnell, John A. Laurie, Michael Kahn, Journal of Clinical Oncology	1998	414
Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group. Charles L. Loprinzi, John A. Laurie, Harry S. Wieand, Journal of Clinical Oncology	1994	376
Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. Michael A. Poon, M. J. OʼConnell, Harry S. Wieand, Journal of Clinical Oncology Tumor BiologyBiochemical ModulationConfirmatory EvidenceChemoprevention StrategyGastrointestinal Oncology	1991	374
Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Jeffrey A. Moscow, Craig R. Fairchild, Mary Madden, PubMed GlycobiologyPathologyP-glycoprotein GenesCancer BiologyTumor Biology	1989	352
Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer. T Buroker, M J O'Connell, Harry S. Wieand, Journal of Clinical Oncology	1994	312

Page 1